This Famed Company Is Working On A Potential Monkeypox Vaccine

As cases of monkeypox continue to rise, Moderna Inc MRNA is probably working on its platform towards finding a vaccine shot against the disease.
The company announced plans to explore potential vaccines for monkeypox at a "preclinical level," according to an announcement on Twitter.
Due to the similarity between the two diseases, the smallpox vaccine is effective against monkeypox.
Unlike COVID-19, which spreads primarily through airborne transmission and the passing of tiny droplets, monkeypox is contracted through close physical contact.
People who contract the disease often develop a contagious rash to the touch.
Also Read: WHO Says Monkeypox Outbreak 'Unusual' But 'Containable'
Meanwhile, the World Health Organization does not believe the monkeypox outbreak outside of Africa requires mass vaccinations.
A senior official said that good hygiene and safe sexual behavior would help control its spread.
Germany's government said that it was assessing options for vaccinations, while Britain has offered them to some healthcare workers.
Germany has ordered 40,000 doses of a Bavarian Nordic BVNKF vaccine to be ready to vaccinate contacts of those infected with monkeypox if an outbreak in Germany becomes more severe.
Price Action: MRNA shares are down 4.99% at $130.75 during the market session on the last check Tuesday.